Craig Lichtenstein

Craig Lichtenstein has extensive work experience in the biotechnology and finance industries. Craig currently holds the position of Chief Operating Officer at EpiBiologics, Inc., a role they have held since June 2022. Prior to this, Craig served as Vice President of Manufacturing at Sana Biotechnology, Inc. from April 2019 to June 2022. Craig also held senior positions at Achaogen, where they served as Vice President & Head of Technical Operations from July 2018 to March 2019, and as Vice President of Manufacturing from November 2017 to June 2018. Before joining Achaogen, Craig worked at Genentech as a Technical Product Leader from August 2013 to November 2016. Craig also held various roles at Genentech, including Director of Pilot Plants from 2010 to 2013 and Operations Manager, Drug Product from 2006 to 2010. Craig's early career includes positions as an Associate at Pequot Capital from 2000 to 2002 and as a Financial Analyst at Cowen and Company from 1998 to 2000.

Craig Lichtenstein's education history reveals that they attended Harvard Business School from 2002 to 2004. However, it is not specified whether they obtained a degree or pursued a specific field of study during their time at this institution. Prior to their enrolment at Harvard, they attended Brown University from 1994 to 1998, where they earned a Bachelor's Degree in Business/Managerial Economics.